Trials / Conditions / Somatostatin Receptor Positive
Somatostatin Receptor Positive
4 registered clinical trials studyying Somatostatin Receptor Positive — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in P NCT06441331 | ITM Solucin GmbH | Phase 1 |
| Recruiting | [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrin NCT06479811 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal NCT06427798 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Withdrawn | Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endo NCT04106843 | M.D. Anderson Cancer Center | Phase 2 |